UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs

B. H. Cuthbertson; P. Dellinger; O. J. Dyar; T. E. Evans; T. Higenbottam; R. Latimer; D. Payen; S. A. Stott; N. R. Webster; J. D. Young

doi:10.1007/s001340050488

UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs

B. H. Cuthbertson^*, P. Dellinger, O. J. Dyar, T. E. Evans, T. Higenbottam, R. Latimer, D. Payen, S. A. Stott, N. R. Webster, J. D. Young

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

74 Citations (Scopus)

Abstract

Objective: Although unlicensed, inhaled nitric oxide (NO) therapy is now widely used in the United Kingdom. Our aim was to produce guidelines for the clinical application of inhaled NO in adult intensive care practice, based upon the current level of published information. Methods: The published data regarding the use of inhaled NO in the acute respiratory distress syndrome and right-sided cardiac failure was presented, analysed and discussed. Recommendations based on these data as well as on current experience in the United Kingdom were formulated. Design: An expert group comprising intensive care specialists from within the United Kingdom, representatives from the European Society of Intensive Care Medicine and the Society of Critical Care Medicine and individuals from the Departments of Health and Industry related to the field was assembled. Results: United Kingdom guidelines for the indications, contraindications, dose, delivery, monitoring and scavenging of inhaled NO therapy were produced. Conclusions: The need for additional quality research to establish evidence of efficacy and safety was emphasized. The guidelines are designed to act within the context of current practice and knowledge and should be revised as further data emerge.

Original language	English
Pages (from-to)	1212-1218
Number of pages	7
Journal	Intensive Care Medicine
Volume	23
Issue number	12
DOIs	https://doi.org/10.1007/s001340050488
Publication status	Published - 1997

Bibliographical note

Funding Information:
Acknowledgements Brian H. Cuthbertson is supported by the "Intavent" Association of Anaesthetists and Royal College of Anaesthetists scholarship.

Keywords

Acute respiratory failure
ARDS
Hypoxaemia
Inhaled nitric oxide
Practice guidelines
Pulmonary hypertension

Access to Document

10.1007/s001340050488

Cite this

@article{7922dfd4766444baa7a9a7f57b4173d5,

title = "UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs",

abstract = "Objective: Although unlicensed, inhaled nitric oxide (NO) therapy is now widely used in the United Kingdom. Our aim was to produce guidelines for the clinical application of inhaled NO in adult intensive care practice, based upon the current level of published information. Methods: The published data regarding the use of inhaled NO in the acute respiratory distress syndrome and right-sided cardiac failure was presented, analysed and discussed. Recommendations based on these data as well as on current experience in the United Kingdom were formulated. Design: An expert group comprising intensive care specialists from within the United Kingdom, representatives from the European Society of Intensive Care Medicine and the Society of Critical Care Medicine and individuals from the Departments of Health and Industry related to the field was assembled. Results: United Kingdom guidelines for the indications, contraindications, dose, delivery, monitoring and scavenging of inhaled NO therapy were produced. Conclusions: The need for additional quality research to establish evidence of efficacy and safety was emphasized. The guidelines are designed to act within the context of current practice and knowledge and should be revised as further data emerge.",

keywords = "Acute respiratory failure, ARDS, Hypoxaemia, Inhaled nitric oxide, Practice guidelines, Pulmonary hypertension",

author = "Cuthbertson, {B. H.} and P. Dellinger and Dyar, {O. J.} and Evans, {T. E.} and T. Higenbottam and R. Latimer and D. Payen and Stott, {S. A.} and Webster, {N. R.} and Young, {J. D.}",

note = "Funding Information: Acknowledgements Brian H. Cuthbertson is supported by the {"}Intavent{"} Association of Anaesthetists and Royal College of Anaesthetists scholarship.",

year = "1997",

doi = "10.1007/s001340050488",

language = "English",

volume = "23",

pages = "1212--1218",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer Verlag",

number = "12",

}

TY - JOUR

T1 - UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs

AU - Cuthbertson, B. H.

AU - Dellinger, P.

AU - Dyar, O. J.

AU - Evans, T. E.

AU - Higenbottam, T.

AU - Latimer, R.

AU - Payen, D.

AU - Stott, S. A.

AU - Webster, N. R.

AU - Young, J. D.

N1 - Funding Information: Acknowledgements Brian H. Cuthbertson is supported by the "Intavent" Association of Anaesthetists and Royal College of Anaesthetists scholarship.

PY - 1997

Y1 - 1997

N2 - Objective: Although unlicensed, inhaled nitric oxide (NO) therapy is now widely used in the United Kingdom. Our aim was to produce guidelines for the clinical application of inhaled NO in adult intensive care practice, based upon the current level of published information. Methods: The published data regarding the use of inhaled NO in the acute respiratory distress syndrome and right-sided cardiac failure was presented, analysed and discussed. Recommendations based on these data as well as on current experience in the United Kingdom were formulated. Design: An expert group comprising intensive care specialists from within the United Kingdom, representatives from the European Society of Intensive Care Medicine and the Society of Critical Care Medicine and individuals from the Departments of Health and Industry related to the field was assembled. Results: United Kingdom guidelines for the indications, contraindications, dose, delivery, monitoring and scavenging of inhaled NO therapy were produced. Conclusions: The need for additional quality research to establish evidence of efficacy and safety was emphasized. The guidelines are designed to act within the context of current practice and knowledge and should be revised as further data emerge.

AB - Objective: Although unlicensed, inhaled nitric oxide (NO) therapy is now widely used in the United Kingdom. Our aim was to produce guidelines for the clinical application of inhaled NO in adult intensive care practice, based upon the current level of published information. Methods: The published data regarding the use of inhaled NO in the acute respiratory distress syndrome and right-sided cardiac failure was presented, analysed and discussed. Recommendations based on these data as well as on current experience in the United Kingdom were formulated. Design: An expert group comprising intensive care specialists from within the United Kingdom, representatives from the European Society of Intensive Care Medicine and the Society of Critical Care Medicine and individuals from the Departments of Health and Industry related to the field was assembled. Results: United Kingdom guidelines for the indications, contraindications, dose, delivery, monitoring and scavenging of inhaled NO therapy were produced. Conclusions: The need for additional quality research to establish evidence of efficacy and safety was emphasized. The guidelines are designed to act within the context of current practice and knowledge and should be revised as further data emerge.

KW - Acute respiratory failure

KW - ARDS

KW - Hypoxaemia

KW - Inhaled nitric oxide

KW - Practice guidelines

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=15144360496&partnerID=8YFLogxK

U2 - 10.1007/s001340050488

DO - 10.1007/s001340050488

M3 - Article

C2 - 9470075

AN - SCOPUS:15144360496

SN - 0342-4642

VL - 23

SP - 1212

EP - 1218

JO - Intensive Care Medicine

JF - Intensive Care Medicine

IS - 12

ER -

UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this